Factors predictive of response, disease progression, and overall survival after dabrafenib and trametinib combination treatment: a pooled analysis of individual patient data from randomised trials
published in: Lancet Oncology Commission
date of publication: 2016-11-15
language: English
main subject: patient
Cites articles 23
- 2002-06-27
Date
Title
Article - wd:Q31143336